A new double-blind, placebo-controlled, multi-centre trial published in Neurogastroenterology & Motility demonstrated that over 90% of patients gained effective relief from Irritable Bowel Syndrome ...
Silicolgel, a colloidal silicic acid enterosorbent, was generally safe and well tolerated, and it significantly reduced symptom severity in adults with irritable bowel syndrome, with efficacy being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results